ACADIA Pharmaceuticals Inc
General ticker "ACAD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.8B
ACADIA Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -25.6%.
Estimated limits based on current volatility of 2.6%: low 16.38$, high 17.26$
Factors to consider:
- Current price 30.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [24.26$, 43.08$]
- 2024-12-30 to 2025-12-30 estimated range: [25.61$, 45.20$]
Financial Metrics affecting the ACAD estimates:
- Negative: Non-GAAP EPS, $ of -0.38 <= 0.10
- Negative: Operating profit margin, % of -9.17 <= 1.03
- Negative: Operating cash flow per share per price, % of 0.41 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
Short-term ACAD quotes
Long-term ACAD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $484.14MM | $517.24MM | $726.44MM |
| Operating Expenses | $654.58MM | $740.83MM | $799.82MM |
| Operating Income | $-170.44MM | $-223.60MM | $-73.38MM |
| Non-Operating Income | $2.92MM | $10.15MM | $22.34MM |
| Interest Expense | $0.00MM | $6.61MM | $0.00MM |
| R&D Expense | $239.41MM | $361.57MM | $351.62MM |
| Income(Loss) | $-167.52MM | $-213.44MM | $-51.04MM |
| Taxes | $0.35MM | $2.53MM | $10.25MM |
| Profit(Loss) | $-167.87MM | $-215.97MM | $-61.29MM |
| Stockholders Equity | $540.89MM | $400.41MM | $431.75MM |
| Inventory | $7.88MM | $6.64MM | $35.82MM |
| Assets | $700.12MM | $587.81MM | $748.96MM |
| Operating Cash Flow | $-125.66MM | $-114.03MM | $16.70MM |
| Capital expenditure | $1.12MM | $0.00MM | $40.05MM |
| Investing Cash Flow | $-71.10MM | $73.24MM | $32.00MM |
| Financing Cash Flow | $18.16MM | $8.20MM | $25.13MM |
| Earnings Per Share* | $-1.05 | $-1.34 | $-0.37 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.